Jannet C Beukema1, Peter van Luijk2, Joachim Widder2, Johannes A Langendijk2, Christina T Muijs2. 1. Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Electronic address: j.c.beukema@umcg.nl. 2. Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Abstract
PURPOSE: In recent years several papers have been published on radiation-induced cardiac toxicity, especially in breast cancer patients. However, in esophageal cancer patients the radiation dose to the heart is usually markedly higher. To determine whether radiation-induced cardiac toxicity is also a relevant issue for this group, we conducted a review of the current literature. METHODS: A literature search was performed in Medline for papers concerning cardiac toxicity in esophageal cancer patients treated with radiotherapy with or without chemotherapy. RESULTS: The overall crude incidence of symptomatic cardiac toxicity was as high as 10.8%. Toxicities corresponded with several dose-volume parameters of the heart. The most frequently reported complications were pericardial effusion, ischemic heart disease and heart failure. CONCLUSION: Cardiac toxicity is a relevant issue in the treatment of esophageal cancer. However, valid Normal Tissue Complication Probability models for esophageal cancer are not available at present.
PURPOSE: In recent years several papers have been published on radiation-induced cardiac toxicity, especially in breast cancerpatients. However, in esophageal cancerpatients the radiation dose to the heart is usually markedly higher. To determine whether radiation-induced cardiac toxicity is also a relevant issue for this group, we conducted a review of the current literature. METHODS: A literature search was performed in Medline for papers concerning cardiac toxicity in esophageal cancerpatients treated with radiotherapy with or without chemotherapy. RESULTS: The overall crude incidence of symptomatic cardiac toxicity was as high as 10.8%. Toxicities corresponded with several dose-volume parameters of the heart. The most frequently reported complications were pericardial effusion, ischemic heart disease and heart failure. CONCLUSION:Cardiac toxicity is a relevant issue in the treatment of esophageal cancer. However, valid Normal Tissue Complication Probability models for esophageal cancer are not available at present.
Authors: Keith Unger; Yaoxiang Li; Celine Yeh; Ana Barac; Monvadi B Srichai; Elizabeth A Ballew; Michael Girgis; Meth Jayatilake; Vijayalakshmi Sridharan; Marjan Boerma; Amrita K Cheema Journal: Radiother Oncol Date: 2020-04-20 Impact factor: 6.280
Authors: Eric D Morris; Ahmed I Ghanem; Milan V Pantelic; Eleanor M Walker; Xiaoxia Han; Carri K Glide-Hurst Journal: Int J Radiat Oncol Biol Phys Date: 2018-11-22 Impact factor: 7.038
Authors: Milan Vošmik; Miroslav Hodek; David Buka; Petra Sýkorová; Jakub Grepl; Petr Paluska; Simona Paulíková; Igor Sirák Journal: Rep Pract Oncol Radiother Date: 2020-02-25